Verve Therapeutics Inc. (VERV)
NASDAQ: VERV
· Real-Time Price · USD
11.15
0.04 (0.36%)
At close: Jun 24, 2025, 3:59 PM
11.09
-0.54%
Pre-market: Jun 25, 2025, 06:02 AM EDT
0.36% (1D)
Bid | 11.02 |
Market Cap | 993.95M |
Revenue (ttm) | 59.61M |
Net Income (ttm) | -181.01M |
EPS (ttm) | -2.11 |
PE Ratio (ttm) | -5.28 |
Forward PE | -4.04 |
Analyst | Hold |
Ask | 11.15 |
Volume | 2,730,449 |
Avg. Volume (20D) | 5,253,795 |
Open | 11.15 |
Previous Close | 11.11 |
Day's Range | 11.09 - 11.19 |
52-Week Range | 2.87 - 11.40 |
Beta | 1.68 |
About VERV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VERV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VERV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Verve Therapeutics Inc. is scheduled to release its earnings on Aug 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+81.5%
Verve Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+3.61%
Verve Therapeutics shares are trading higher after the company reported a year-over-year increase for Q1 EPS results.